ABSTRACT
Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases of the developed world and interest in the condition is burgeoning both among physicians encountering the disorder and within the pharmaceutical industry. International guidelines for diagnosis and management have been formulated and our basic understanding
